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Abstract Background: We have recently explored the
detection of circulatory male fetal cells directly in
maternal whole blood samples by ﬂuorescence in-situ
hybridization (FISH). In order to improve the eﬃcacy of
fetal cell detection, we have now examined whether this
could be enhanced by the use of two diﬀerent Y chro-
mosome-speciﬁc FISH probes (a-satellite and classical
satellite III regions) in combination with an X chromo-
some-speciﬁc FISH probe. Methods: Nineteen maternal
blood samples (median gestational age=28 weeks,
range=12–37 weeks) were examined in a blinded man-
ner. No enrichment procedure was performed. Following
hypotonic treatment and Carnoy’s ﬁxation, total nucle-
ated cells were examined by two color FISH with a single
X and two Y chromosome-speciﬁc probes. Nine cases
were examined in parallel by conventional XY-FISH.
Results: Fetal cell detection was superior when using two
Y chromosome-speciﬁc probes (speciﬁcity=75%; sensi-
tivity=91%) when compared to the conventional XY-
FISH approach (speciﬁcity=50%; sensitivity=60%).
Conclusions: Male fetal cells can be detected in most
maternal blood samples examined. Speciﬁcity and sen-
sitivity is improved when using a combination of single X
and two Y chromosome-speciﬁc probes when compared
to a conventional XY-FISH protocol.
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Introduction
Even though fetal genetic loci such as RhD status or sex
can now be reliably determined by the analysis of
cell-free fetal DNA in maternal plasma, this approach is
currently not suited for the analysis of complex fetal
genetic traits, such as those involved in the case of fetal
aneuploidies [4, 5]. For this reason the enrichment and
analysis of fetal cells from maternal blood samples is
currently still the most promising strategy for the non-
invasive determination of numerical anomalies of fetal
chromosomes, such as those involved in Down’s
syndrome [5].
Large scale studies, using either MACS (magnetic cell
separation) or FACS (ﬂuorescent activated cell sorting),
have however indicated that fetal cells, speciﬁcally fetal
erythroblasts, cannot be reliably retrieved and analyzed
from maternal blood samples [2, 3]. These results have
raised the question of whether the fetal cells, especially
erythroblasts, were indeed present in each pregnancy
examined [9]. Furthermore, it appears that the fetal
erythroblast may not be the optimal target cell, and that
it may be necessary to examine for other more suitable
fetal cell types [1, 6].
In this context a recent study has indicated that fetal
cells can be detected by the use of ﬂuorescence in-situ
hybridization (FISH) in maternal whole blood samples
without any form of enrichment [7). These results are of
considerable importance as they yield vital information
concerning the number of circulating fetal cells in
maternal blood. It is also hoped that by the analysis of
these cells, other more optimal target fetal cells types
may be identiﬁed.
Prompted by these analyses we have recently exam-
ined the feasibility of detecting fetal cells directly with-
out any form of enrichment in maternal blood samples
[8]. This study indicated that fetal cells were indeed
present in the majority of samples examined, and
that they were present with astonishingly high frequency
(12–20 fetal cells/ml maternal blood) [8]. In our
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examination, we also observed that the speciﬁcity of
detecting male fetal cells could be improved by the use of
two diﬀerent Y chromosome-speciﬁc FISH probes (a
and III satellite: speciﬁcity=89.5%) when compared to
a conventional XY-FISH protocol (speciﬁcity=68.4%)
[8]. As the sensitivity of the latter approach was however
quite poor (42.9%), we have attempted to further en-
hance the eﬃcacy of this approach. For this reason, we
have examined the use of two similar Y chromosome-
speciﬁc FISH probes (a and III satellite), but now in
combination with a conventional centromeric X chro-
mosome-speciﬁc FISH probe (referred to as XYY-
FISH). We have also compared this approach to con-
ventional XY-FISH.
Materials and methods
Sample recruitment and processing
Nineteen healthy pregnant women between the 12th and
37th weeks of gestation were recruited for this study,
which was approved by the Ethical Review Board of the
University of Basel. Written informed consent was ob-
tained in all instances. The maternal whole blood sam-
ples, anti-coagulated with EDTA, were processed within
6 h as described previously [7, 8]. In brief, 500 ll of
EDTA-blood was washed with 8 ml RPMI 1640 med-
ium (Invitrogen, Basel, Switzerland), incubated with
10 ml prewarmed 0.4% KCl for 20 min at 37C, ﬁxed
several times with freshly prepared pre-chilled Carnoy‘s
ﬁxative (methanol:glacial acetic acid, 3:1), washed with
1% BSA/PBS and transferred by cytocentrifugation
onto glass slides (four slides per case). Prior to FISH
analysis the slide preparations were digested with
0.005% pepsin for 10 min at RT and then ﬁxed for
10 min in 1% formaldehyde.
FISH analysis
XYY-FISH
All 19 samples were examined by FISH analysis using
centromeric and III satellite Y chromosome-speciﬁc
probes (Ya satellite rhodamine and Yqh classical sa-
tellite III rhodamine) in combination with a conven-
tional centromeric probe for the X chromosome (Xa
satellite ﬂuorescein) (Qbiogene, Basel, Switzerland).
XY-FISH
Conventional dual-color FISH for the X and Y chro-
mosomes was accomplished using a commercial chro-
mosome enumeration cocktail (CEPX spectrum green
(a-satellite)/CEPY spectrum orange (a-satellite), (Vysis/
ABBOTT Diagnostics, Baar, Switzerland).
All FISH analyses were performed according to the
manufacturer’s instructions, using FISH probes diluted
1:100 in cDenHyb-1 (Insitus Biotechnologies,
Alberquerque, NM, USA) [8]. For XYY-FISH, co-
denaturation was performed at 80C for 2 min, while
that for XY-FISH was carried out at 72C for 8 min. All
hybridizations were carried out at 37C for 6 h. Post-
hybridization washes were performed in 50% formam-
ide/1.5x SSC at 45C (5 min) and in 1.5x SSC at 45C
(2 min). After a ﬁnal wash with distilled water, the slides
were counterstained with 0.01% DAPI/Glycerol (Sigma,
Fluka Chemie GmbH, Buchs, Switzerland).
For each hybridization analysis, male cord blood
control slides were examined in parallel to monitor the
quality of the FISH performance, yielding average eﬃ-
ciencies of greater than 98% for each FISH protocol.
All samples were analyzed in a blinded manner using
a triple pass ﬁlter for the ﬁrst scan and the subsequent
conﬁrmation of individual X and Y chromosome-spe-
ciﬁc FISH signals using the appropriate single band pass
ﬁlters at 630· magniﬁcation (Axiovision 3.1, Carl Zeiss,
Zu¨rich, Switzerland).
In order for a cell to be classiﬁed as fetal, the clear
presence of speciﬁc signals for both X and Y FISH
chromosomes had to be present. Results from the FISH
analysis were only compared to the fetal gender as
determined from birth outcome once the evaluation was
complete.
Results
Our analysis of the 19 maternal blood samples by the
combination of two Y chromosome-speciﬁc FISH
probes in combination with a FISH probe for the X
chromosome (XYY-FISH) indicated that male fetal
cells could be detected with 75% speciﬁcity and 91%
sensitivity (Table 1), indicating that male fetal cells
could be detected in 10 out of the 11 pregnancies with
male fetuses. Our parallel analysis of nine of these
samples by conventional XY-FISH indicated that male
fetal cells could be detected with 50% speciﬁcity and
60% sensitivity (Table 1), which is in good agreement
with our previous results [8]. On the other hand, when
the same samples were analyzed by our new XYY-
FISH approach, male fetal cells could be detected with
100% speciﬁcity and 100% sensitivity. Therefore, the
use of two diﬀerent Y chromosome-speciﬁc FISH
probes in combination with an X chromosome-speciﬁc
FISH does appear to yield a better result than that
obtained by conventional XY-FISH. Furthermore, it
appeared that more male fetal cells were detected by
the XYY-FISH approach, where 1 to 4 fetal cells were
recorded per slide, (yielding an average concentration
of between 8 to 32 fetal cells per ml of maternal
blood), compared to the 1 to 2 fetal cells that were
recorded per slide using conventional XY-FISH. We
also observed that the signals for the Y chromosome
were not as bright and readily identiﬁable using the
conventional XY-FISH approach (Fig. 1a) when
compared to those detected by the novel XYY-FISH
procedure (Fig. 1b).
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Discussion
Previous studies have indicated that male fetal cells can
be detected directly in maternal whole blood samples by
conventional XY-FISH or PRINS (primed in-situ
labelling) [7]. Although these studies yielded important
information concerning the number of circulating fetal
cells in maternal blood, the results are possibly skewed
by the fact that they were not conducted in a blinded
manner.
In a recent study, we have used a similar approach to
that described by Krabchi and colleagues, in that we also
used conventional XY-FISH to detect the presence of
such circulatory male fetal cells, but performed our
analysis in a blinded manner concerning the sex of the
fetus [8]. This analysis indicated that male fetal cells
could be detected with a speciﬁcity of 68.4% and sen-
sitivity of 52.4%. By switching to a protocol in which
male fetal cells were detected solely on the basis of two
independent Y chromosome-speciﬁc FISH signals (a-
and III-satellite), we achieved a speciﬁcity of 89.5% [8].
However, the sensitivity was slightly decreased to 42.9%
[8]. Although this study did indicate that male fetal cells
were present in a large proportion of pregnancies with
male fetuses, we were anxious to improve upon the
accuracy of our method. For this reason we have again
used two similar Y chromosome-speciﬁc FISH probes
(a- and III-satellite), but now in combination with an X
chromosome-speciﬁc FISH probe.
Our current investigation indicates that circulatory
male fetal cells can now be detected with 75% speciﬁcity
Table 1 Detection of male fetal
cells in maternal blood by two
diﬀerent FISH strategies
Case Number of
male fetal cells
detected by
XYY-FISH/ml
maternal blood
Number of male
fetal cells detected
by XY-FISH/ml
maternal blood
Gender of
fetus
1 24 12 Male
2 16 12 Male
3 0 8 Female
4 0 0 Female
5 0 16 Female
6 0 0 Female
7 32 0 Male
8 32 0 Male
9 32 20 Male
10 8 n.t. Female
11 0 n.t. Male
12 0 n.t. Female
13 8 n.t. Male
14 16 n.t. Male
15 32 n.t. Male
16 8 n.t. Male
17 0 n.t. Female
18 24 n.t. Male
19 8 n.t. Female
Sensitivity 91% 60%
Speciﬁcity 75% 50%
Fig. 1 a Detection of a male
fetal cell in maternal blood by
conventional XY-FISH. b
Detection of a male fetal cell in
maternal blood by the use of
two Y chromosome-speciﬁc (a-
and III-satellite) FISH probes
in combination with a FISH
probe speciﬁc for the X
chromosome (XYY-FISH)
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and 91% sensitivity, which is a considerable improve-
ment over previous results. The eﬃcacy of this approach
also becomes readily apparent in our parallel assessment
of the same samples by conventional XY-FISH, where
male fetal cells could only be detected with 50% speci-
ﬁcity and 60% sensitivity.
Our data are also quite encouraging with regard to
the number of male fetal cells detected per ml of
maternal blood, in that these may also be slightly higher
than our previous estimates (8–32 vs. 12–20). Akin to
our previous study, male fetal cells could be detected in
the majority of maternal blood samples examined. Al-
though encouraging, it is clear that these results will
have to be conﬁrmed in a larger study. It will be par-
ticularly important to determine at what stage of preg-
nancy circulatory cells can be detected reliably, since in
our current study we examined a broad spectrum of
gestational ages. It will also be important to determine
their frequency early in pregnancy at those stages where
they may be useful as the basis for a non-invasive pre-
natal diagnosis, particularly in the ﬁrst trimester (5).
Furthermore, the fetal source (placental or hemopoietic)
of these cells is also of considerable interest, as this could
lead to the development of new tools permitting their
eﬃcacious isolation from maternal blood samples.
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